Semiconductors Healthcare Sector

Relay Therapeutics

Market Cap: US$533.2m

Operates as a clinical-stage precision medicines company.

Enhabit

Market Cap: US$529.7m

Provides home health and hospice services in the United States.

Clarity Pharmaceuticals

Market Cap: AU$822.7m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Stoke Therapeutics

Market Cap: US$527.4m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Kura Oncology

Market Cap: US$527.2m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Akso Health Group

Market Cap: US$526.1m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Definitive Healthcare

Market Cap: US$523.9m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Axogen

Market Cap: US$518.7m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Community Health Systems

Market Cap: US$516.3m

Owns, leases, and operates general acute care hospitals in the United States.

Talkspace

Market Cap: US$515.3m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

UroGen Pharma

Market Cap: US$513.6m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

InnovAge Holding

Market Cap: US$513.3m

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Auna

Market Cap: US$512.6m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Upstream Bio

Market Cap: US$511.0m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Healius

Market Cap: AU$787.9m

Provides specialty diagnostic services to consumer and practitioners in Australia.

Botanix Pharmaceuticals

Market Cap: AU$771.8m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Castle Biosciences

Market Cap: US$492.0m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Orthofix Medical

Market Cap: US$487.0m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Sonida Senior Living

Market Cap: US$485.8m

Owns and operates senior housing communities in the United States.

Delcath Systems

Market Cap: US$483.2m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Mind Medicine (MindMed)

Market Cap: US$481.3m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

CytoDyn

Market Cap: US$476.0m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Arvinas

Market Cap: US$475.9m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Taysha Gene Therapies

Market Cap: US$475.7m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Fortrea Holdings

Market Cap: US$469.9m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Cullinan Therapeutics

Market Cap: US$466.8m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Alliance Pharma

Market Cap: UK£350.3m

A holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.

Eton Pharmaceuticals

Market Cap: US$465.3m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Elite Pharmaceuticals

Market Cap: US$464.6m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Altimmune

Market Cap: US$462.9m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

PYC Therapeutics

Market Cap: AU$717.4m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Tilray Brands

Market Cap: US$459.1m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Cross Country Healthcare

Market Cap: US$456.3m

Provides talent management services for healthcare clients in the United States.

Treace Medical Concepts

Market Cap: US$452.6m

A medical technology company, designs, manufactures, and markets medical devices in the United States.